Pierre Blanchard

16.1k total citations · 2 hit papers
288 papers, 7.9k citations indexed

About

Pierre Blanchard is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Pierre Blanchard has authored 288 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Otorhinolaryngology, 118 papers in Pulmonary and Respiratory Medicine and 96 papers in Surgery. Recurrent topics in Pierre Blanchard's work include Head and Neck Cancer Studies (116 papers), Advanced Radiotherapy Techniques (57 papers) and Head and Neck Surgical Oncology (40 papers). Pierre Blanchard is often cited by papers focused on Head and Neck Cancer Studies (116 papers), Advanced Radiotherapy Techniques (57 papers) and Head and Neck Surgical Oncology (40 papers). Pierre Blanchard collaborates with scholars based in France, United States and China. Pierre Blanchard's co-authors include Anthony T.�C. Chan, Jun Ma, Yu‐Pei Chen, Quynh‐Thu Le, Ying Sun, Jean‐Pierre Pignon, Jean Bourhis, H. Mirghani, Steven J. Frank and Abderrahmane Bourredjem and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Pierre Blanchard

265 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nasopharyngeal carcinoma

2019 2.0k citations Quynh‐Thu Le, Pierre Blanchard et al. profile →
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site

2011 431 citations Pierre Blanchard, Jean Bourhis et al. Radiotherapy and Oncology profile →

Peers

Countries citing papers authored by Pierre Blanchard

Since Specialization

Citations

This map shows the geographic impact of Pierre Blanchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Blanchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Blanchard more than expected).

Fields of papers citing papers by Pierre Blanchard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Blanchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Blanchard. The network helps show where Pierre Blanchard may publish in the future.

Co-authorship network of co-authors of Pierre Blanchard

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Blanchard. A scholar is included among the top collaborators of Pierre Blanchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Blanchard. Pierre Blanchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intensification or de-escalation? What is the standard treatment for human papillomavirus-related oropharyngeal cancers in 2025? 2025 ·Cancer/Radiothérapie ·Pierre Blanchard, Anne Aupérin, David Veyer, Hélène Péré, Michaël Chevrot, Laure Monard, (unknown), H. Mirghani	1
2	World-wide oligometastatic prostate cancer (omPC) meta-analysis leveraging individual patient data (IPD) from randomized trials (WOLVERINE): An analysis from the X-MET collaboration. 2025 ·Journal of Clinical Oncology ·Chad Tang, Alexander D. Sherry, Hyunsoo Hwang, Giulio Francolini, (unknown), Phuoc T. Tran, Paul G. Corn, Ana M. Aparicio, Gabriele Simontacchi, Ana P. Kiess, Jarey H. Wang, Valérie Fonteyne, Renée Bultijnck, Robert Olson, Stephen Harrow, Ethan B. Ludmir, Pierre Blanchard, (unknown), David A. Palma, David E. Ost	9
3	2449 Postoperative SBRT for Early-Stage Oropharyngeal and Oral Cavity Cancers with High-Risk Margins: the STEREOPOSTOP GORTEC 2017-03 phase 2 trial 2025 ·Radiotherapy and Oncology ·J. Biau, Xu-Shan Sun, X. Liem, Jean Faivre, Pierre Blanchard, (unknown), Yungan Tao, F. Huguet, Jean Bourhis, M. Lapeyre	1
4	Radiotherapy for nasopharyngeal cancer: 2025 update 2025 ·Cancer/Radiothérapie ·(unknown), J. Biau, (unknown), S. Racadot, (unknown), L. Vieillevigne, Y. Pointreau, Pierre Blanchard	0
5	Outcomes and level of evidence in radiation therapy research and different categories of radiotherapy innovations: an ESTRO-VBRO bibliometrics analysis of the literature 2025 ·Radiotherapy and Oncology ·(unknown), Grant Lewison, (unknown), Josep M. Borràs, Michelle Leech, (unknown), Pierre Blanchard, Yolande Lievens, Ajay Aggarwal	2
6	Correlation Between Electronic Patient-Reported Outcomes and Biological Markers of Key Parameters in Acute Radiation Cystitis Among Patients With Prostate Cancer (RABBIO): Prospective Observational Study 2024 ·JMIR Cancer ·Carole Hélissey, (unknown), (unknown), (unknown), Charles Parnot, Antoine Schernberg, (unknown), (unknown), (unknown), Stanislas Mondot, Christos Christopoulos, (unknown), (unknown), Pierre Blanchard, Cyrus Chargari, Sabine François	1
7	Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapy 2023 ·Cancer/Radiothérapie ·(unknown), (unknown), (unknown), S. Thureau, Y. Pointreau, Pierre Blanchard, Juliette Thariat	3
8	Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses 2023 ·Radiotherapy and Oncology ·Elaine Johanna Limkin, Pierre Blanchard, Benjamin Lacas, Jean Bourhis, Mahesh Parmar, Lisa Licitra, Quynh‐Thu Le, Sue S. Yom, Catherine Fortpied, Johannes A. Langendijk, Jan B. Vermorken, Jacques Bernier, Jens Overgaard, Jonathan Harris, Jean‐Pierre Pignon, Anne Aupérin	1
9	Practice changing data and emerging concepts from recent radiation therapy randomised clinical trials 2022 ·European Journal of Cancer ·Sophie Espenel, Cyrus Chargari, Pierre Blanchard, Sophie Bockel, Daphné Morel, Sofía Rivera, Antonin Lévy, Éric Deutsch	6
10	Penalized Poisson model for network meta-analysis of individual patient\n time-to-event data 2021 ·arXiv (Cornell University) ·Édouard Ollier, Pierre Blanchard, Gwénaël Le Teuff, Stefan Michiels	4
11	Disease-free time stratification in locally recurrent head and neck carcinoma after definitive radiotherapy or chemoradiotherapy 2021 ·European Archives of Oto-Rhino-Laryngology ·Philippe Gorphe, Antoine Moya‐Plana, Joanne Guerlain, Yungan Tao, F. Nguyen, Ingrid Breuskin, Pierre Blanchard, Stéphane Temam	3
12	Manufacturing Firms As Services Providers: What The Belgian Data Show 2020 ·Économie & prévision ·Pierre Blanchard, Catherine Fuss, (unknown)	0
13	Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced nasopharyngeal carcinomas 2019 ·Systematic Reviews ·Claire Petit, Pierre Blanchard, Jean‐Pierre Pignon, B. Lueza	11
14	Brachytherapy: An overview for clinicians 2019 ·CA A Cancer Journal for Clinicians ·Cyrus Chargari, Éric Deutsch, Pierre Blanchard, Sébastien Gouy, Hélène Martelli, Florent Guérin, Isabelle Dumas, Alberto Bossi, Philippe Morice, Akila N. Viswanathan, Christine Haie‐Méder	191
15	Clinical outcomes after interstitial brachytherapy for early-stage nasal squamous cell carcinoma 2017 ·Brachytherapy ·(unknown), Alexandre Escande, Stéphane Temam, Isabelle Dumas, Émilie Routier, (unknown), Pierre Blanchard, François Janot, Christine Mateus, Yungan Tao, Caroline Robert, Éric Deutsch, Christine Haie‐Méder, Cyrus Chargari	12
16	Méta-analyses en réseau : intérêt et limites en oncologie 2016 ·Bulletin du Cancer ·Laureen Ribassin-Majed, Jean‐Pierre Pignon, Stefan Michiels, Pierre Blanchard	0
17	Radiothérapie des cancers du nasopharynx 2016 ·Cancer/Radiothérapie ·P. Maingon, Pierre Blanchard, (unknown), L. Calmels	8
18	The shadow of death model revisited with an application to French firms 2014 ·Applied Economics ·Pierre Blanchard, (unknown), (unknown)	8
19	Comparison of Dose Distribution between Intensity Modulated Radiation Therapy and Dynamic Arc Therapy in and out-of- Field for Prostate Cancer Treatment 2013 ·(unknown), (unknown), J. Chavaudra, (unknown), (unknown), Rodrigue S. Allodji, Tao Gan, Pierre Blanchard, (unknown), A. Bridier, Dimitri Lefkopoulos, Florent de Vathaire, Ibrahima Diallo	0
20	Optimisation de l’« involved-node radiotherapy » par l’utilisation de la modulation d’intensité dans le lymphome hodgkinien localisé : expérience de l’institut Gustave-Roussy 2011 ·Cancer/Radiothérapie ·A. Paumier, (unknown), A. Beaudré, Mithra Ghalibafian, Pierre Blanchard, (unknown), (unknown), N. Lessard, T. Girinsky	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact